Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Published Online
on October 28, 2002

Circulation. 2002
Published online before print October 28, 2002, doi: 10.1161/01.CIR.0000038364.26310.BD
A more recent version of this article appeared on November 19, 2002
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
106/21/2659    most recent
01.CIR.0000038364.26310.BDv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brunner, E. J.
Right arrow Articles by Marmot, M. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brunner, E. J.
Right arrow Articles by Marmot, M. G.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*HYDROCORTISONE
Medline Plus Health Information
*Metabolic Syndrome
Related Collections
Right arrow Epidemiology
Right arrow Autonomic, reflex, and neurohumoral control of circulation
Right arrow Glucose intolerance
Right arrowRelated Article

Submitted on July 22, 2002
Revised on September 6, 2002
Accepted on September 6, 2002

Adrenocortical, Autonomic, and Inflammatory Causes of the Metabolic Syndrome. Nested Case-Control Study

E. J. Brunner PhD*, H. Hemingway MRCP, B. R. Walker MD, M. Page MRes, P. Clarke PhD, M. Juneja BSc, M. J. Shipley MSc, M. Kumari PhD, R. Andrew PhD, J. R. Seckl MBBS, PhD, A. Papadopoulos PhD, S. Checkley FRCP, A. Rumley PhD, G. D.O. Lowe MD, FRCP, S. A. Stansfeld PhD, and M. G. Marmot PhD, FRCP

From the International Centre for Health and Society, Department of Epidemiology and Public Health, University College London, England; Endocrinology Unit (B.R.W., R.A., J.R.S.), Western General Hospital, University of Edinburgh, Scotland; Institute of Psychiatry (A.P., S.C.), Bethlem Royal Hospital, London, England; Department of Medicine (A.R., G.D.O.L.), Royal Infirmary, University of Glasgow, Scotland; and Department of Community Psychiatry (S.A.S.), Queen Mary and Westfield College, London, England.

* To whom correspondence should be addressed. E-mail: e.brunner{at}ucl.ac.uk.

Background—The causes of metabolic syndrome (MS), which may be a precursor of coronary disease, are uncertain. We hypothesize that disturbances in neuroendocrine and cardiac autonomic activity (CAA) contribute to development of MS. We examine reversibility and the power of psychosocial and behavioral factors to explain the neuroendocrine adaptations that accompany MS.

Methods and Results—This was a double-blind case-control study of working men aged 45 to 63 years drawn from the Whitehall II cohort. MS cases (n=30) were compared with healthy controls (n=153). Cortisol secretion, sensitivity, and 24-hour cortisol metabolite and catecholamine output were measured over 2 days. CAA was obtained from power spectral analysis of heart rate variability (HRV) recordings. Twenty-four-hour cortisol metabolite and normetanephrine (3-methoxynorepinephrine) outputs were higher among cases than controls (+0.49, +0.45 SD, respectively). HRV and total power were lower among cases (both -0.72 SD). Serum interleukin-6, plasma C-reactive protein, and viscosity were higher among cases (+0.89, +0.51, and +0.72 SD). Lower HRV was associated with higher normetanephrine output (r=-0.19; P=0.03). Among former cases (MS 5 years previously, n=23), cortisol output, heart rate, and interleukin-6 were at the level of controls. Psychosocial factors accounted for 37% of the link between MS and normetanephrine output, and 7% to 19% for CAA. Health-related behaviors accounted for 5% to 18% of neuroendocrine differences.

Conclusions—Neuroendocrine stress axes are activated in MS. There is relative cardiac sympathetic predominance. The neuroendocrine changes may be reversible. This case-control study provides the first evidence that chronic stress may be a cause of MS. Confirmatory prospective studies are required.


Key words: norepinephrine • coronary disease • stress • metabolism • heart rate


Related Article:

Stress and the Metabolic Syndrome: An Interesting but Enigmatic Association
Paul Hjemdahl
Circulation 2002 106: 2634-2636. [Full Text]



This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
D. Gozal, O. S. Capdevila, and L. Kheirandish-Gozal
Metabolic Alterations and Systemic Inflammation in Obstructive Sleep Apnea among Nonobese and Obese Prepubertal Children
Am. J. Respir. Crit. Care Med., May 15, 2008; 177(10): 1142 - 1149.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. J. Weigensberg, C. M. Toledo-Corral, and M. I. Goran
Association between the Metabolic Syndrome and Serum Cortisol in Overweight Latino Youth
J. Clin. Endocrinol. Metab., April 1, 2008; 93(4): 1372 - 1378.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
T. Chandola, A. Britton, E. Brunner, H. Hemingway, M. Malik, M. Kumari, E. Badrick, M. Kivimaki, and M. Marmot
Work stress and coronary heart disease: what are the mechanisms?
Eur. Heart J., March 1, 2008; 29(5): 640 - 648.
[Abstract] [Full Text] [PDF]


Home page
Psychosom. Med.Home page
V. Vaccarino, C. McClure, B. D. Johnson, D. S. Sheps, V. Bittner, T. Rutledge, L. J. Shaw, G. Sopko, M. B. Olson, D. S. Krantz, et al.
Depression, the Metabolic Syndrome and Cardiovascular Risk
Psychosom Med, January 1, 2008; 70(1): 40 - 48.
[Abstract] [Full Text] [PDF]


Home page
Am J Crit CareHome page
L. G. Futterman and L. Lemberg
Inequalities in the Healthcare System: A Problem, Worldwide
Am. J. Crit. Care., November 1, 2007; 16(6): 617 - 620.
[Full Text] [PDF]


Home page
Eur J EndocrinolHome page
B. R Walker
Glucocorticoids and Cardiovascular Disease
Eur. J. Endocrinol., November 1, 2007; 157(5): 545 - 559.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
N.G. ABRAHAM, E.J. BRUNNER, J.W. ERIKSSON, and R.P. ROBERTSON
Metabolic Syndrome: Psychosocial, Neuroendocrine, and Classical Risk Factors in Type 2 Diabetes
Ann. N.Y. Acad. Sci., October 1, 2007; 1113(1): 256 - 275.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
J-M Gonzalez-Clemente, C Vilardell, M Broch, A Megia, A Caixas, O Gimenez-Palop, C Richart, I Simon, A Martinez-Riquelme, J Arroyo, et al.
Lower heart rate variability is associated with higher plasma concentrations of IL-6 in type 1 diabetes
Eur. J. Endocrinol., July 1, 2007; 157(1): 31 - 38.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M.-F. O'Connor, S. J. Motivala, E. M. Valladares, R. Olmstead, and M. R. Irwin
Sex differences in monocyte expression of IL-6: role of autonomic mechanisms
Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2007; 293(1): R145 - R151.
[Abstract] [Full Text] [PDF]


Home page
PsychosomaticsHome page
R. A. Bermudes, P. E. Keck Jr., and J. A. Welge
The Prevalence of the Metabolic Syndrome in Psychiatric Inpatients With Primary Psychotic and Mood Disorders
Psychosomatics, December 1, 2006; 47(6): 491 - 497.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
E. KAJANTIE
Fetal Origins of Stress-Related Adult Disease
Ann. N.Y. Acad. Sci., November 1, 2006; 1083(1): 11 - 27.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
N TENTOLOURIS, S LIATIS, and N KATSILAMBROS
Sympathetic System Activity in Obesity and Metabolic Syndrome
Ann. N.Y. Acad. Sci., November 1, 2006; 1083(1): 129 - 152.
[Abstract] [Full Text] [PDF]


Home page
Psychosom. Med.Home page
J. Zhang, R. Niaura, J. R. Dyer, B.-J. Shen, J. F. Todaro, J. M. McCaffery, A. Spiro III, and K. D. Ward
Hostility and Urine Norepinephrine Interact to Predict Insulin Resistance: The VA Normative Aging Study.
Psychosom Med, September 1, 2006; 68(5): 718 - 726.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
M. Paul-Labrador, D. Polk, J. H. Dwyer, I. Velasquez, S. Nidich, M. Rainforth, R. Schneider, and C. N. B. Merz
Effects of a randomized controlled trial of transcendental meditation on components of the metabolic syndrome in subjects with coronary heart disease.
Arch Intern Med, June 12, 2006; 166(11): 1218 - 1224.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
M. G. Marmot
Status Syndrome: A Challenge to Medicine
JAMA, March 15, 2006; 295(11): 1304 - 1307.
[Full Text] [PDF]


Home page
BMJHome page
T. Chandola, E. Brunner, and M. Marmot
Chronic stress at work and the metabolic syndrome: prospective study
BMJ, March 4, 2006; 332(7540): 521 - 525.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
K. M Oltmanns, B. Dodt, B. Schultes, H. H Raspe, U. Schweiger, J. Born, H. L Fehm, and A. Peters
Cortisol correlates with metabolic disturbances in a population study of type 2 diabetic patients
Eur. J. Endocrinol., February 1, 2006; 154(2): 325 - 331.
[Abstract] [Full Text] [PDF]


Home page
Int J EpidemiolHome page
M.-H. Kim, M.-K. Kim, B. Y. Choi, and Y.-J. Shin
Educational disparities in the metabolic syndrome in a rapidly changing society--the case of South Korea
Int. J. Epidemiol., December 1, 2005; 34(6): 1266 - 1273.
[Abstract] [Full Text] [PDF]


Home page
J Am Board Fam MedHome page
K. E. Innes, C. Bourguignon, and A. G. Taylor
Risk Indices Associated with the Insulin Resistance Syndrome, Cardiovascular Disease, and Possible Protection with Yoga: A Systematic Review
J Am Board Fam Med, November 1, 2005; 18(6): 491 - 519.
[Abstract] [Full Text] [PDF]


Home page
Psychosom. Med.Home page
B. J. Lehman, S. E. Taylor, C. I. Kiefe, and T. E. Seeman
Relation of Childhood Socioeconomic Status and Family Environment to Adult Metabolic Functioning in the CARDIA Study
Psychosom Med, November 1, 2005; 67(6): 846 - 854.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
D. Lucini, G. Di Fede, G. Parati, and M. Pagani
Impact of Chronic Psychosocial Stress on Autonomic Cardiovascular Regulation in Otherwise Healthy Subjects
Hypertension, November 1, 2005; 46(5): 1201 - 1206.
[Abstract] [Full Text] [PDF]


Home page
Occup Med (Lond)Home page
N. Greenberg, M. Henderson, S. Karim, and K. Holland-Elliott
Does having an occupational mental health service make any difference?
Occup. Med., October 1, 2005; 55(7): 549 - 551.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
Y. Liao, S. Takashima, N. Maeda, N. Ouchi, K. Komamura, I. Shimomura, M. Hori, Y. Matsuzawa, T. Funahashi, and M. Kitakaze
Exacerbation of heart failure in adiponectin-deficient mice due to impaired regulation of AMPK and glucose metabolism
Cardiovasc Res, September 1, 2005; 67(4): 705 - 713.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
R. Tauman, L. M. O'Brien, A. Ivanenko, and D. Gozal
Obesity Rather Than Severity of Sleep-Disordered Breathing as the Major Determinant of Insulin Resistance and Altered Lipidemia in Snoring Children
Pediatrics, July 1, 2005; 116(1): e66 - e73.
[Abstract] [Full Text] [PDF]


Home page
Postgrad. Med. J.Home page
S Vale
Psychosocial stress and cardiovascular diseases
Postgrad. Med. J., July 1, 2005; 81(957): 429 - 435.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
H. Hemingway, M. Shipley, E. Brunner, A. Britton, M. Malik, and M. Marmot
Does Autonomic Function Link Social Position to Coronary Risk?: The Whitehall II Study
Circulation, June 14, 2005; 111(23): 3071 - 3077.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. E. la Fleur, H. Houshyar, M. Roy, and M. F. Dallman
Choice of Lard, But Not Total Lard Calories, Damps Adrenocorticotropin Responses to Restraint
Endocrinology, May 1, 2005; 146(5): 2193 - 2199.
[Abstract] [Full Text] [PDF]


Home page
Int J EpidemiolHome page
M. Marmot and E. Brunner
Cohort Profile: The Whitehall II study
Int. J. Epidemiol., April 1, 2005; 34(2): 251 - 256.
[Full Text] [PDF]


Home page
Arch Intern MedHome page
J. P. Curtis, J. G. Selter, Y. Wang, S. S. Rathore, I. S. Jovin, F. Jadbabaie, M. Kosiborod, E. L. Portnay, S. I. Sokol, F. Bader, et al.
The Obesity Paradox: Body Mass Index and Outcomes in Patients With Heart Failure
Arch Intern Med, January 10, 2005; 165(1): 55 - 61.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
R. J. Huggett, J. Burns, A. F. Mackintosh, and D. A.S.G. Mary
Sympathetic Neural Activation in Nondiabetic Metabolic Syndrome and Its Further Augmentation by Hypertension
Hypertension, December 1, 2004; 44(6): 847 - 852.
[Abstract] [Full Text] [PDF]


Home page
ANGIOLOGYHome page
S. S. Daskalopoulou, D. P. Mikhailidis, and M. Elisaf
Prevention and Treatment of the Metabolic Syndrome
Angiology, November 1, 2004; 55(6): 589 - 612.
[Abstract] [PDF]


Home page
Cardiovasc ResHome page
J. P. Girod and D. J. Brotman
Does altered glucocorticoid homeostasis increase cardiovascular risk?
Cardiovasc Res, November 1, 2004; 64(2): 217 - 226.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
A. Britton, M. Shipley, M. Marmot, and H. Hemingway
Does access to cardiac investigation and treatment contribute to social and ethnic differences in coronary heart disease? Whitehall II prospective cohort study
BMJ, August 7, 2004; 329(7461): 318.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
C. J. Weisbrod, P. R. Eastwood, G. O'Driscoll, J. H. Walsh, M. Best, J. R. Halliwill, and D. J. Green
Vasomotor Responses to Hypoxia in Type 2 Diabetes
Diabetes, August 1, 2004; 53(8): 2073 - 2078.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. K. Rutter, J. B. Meigs, L. M. Sullivan, R. B. D'Agostino Sr, and P. W.F. Wilson
C-Reactive Protein, the Metabolic Syndrome, and Prediction of Cardiovascular Events in the Framingham Offspring Study
Circulation, July 27, 2004; 110(4): 380 - 385.
[Abstract] [Full Text] [PDF]


Home page
Psychosom. Med.Home page
L. S. Kinder, M. R. Carnethon, L. P. Palaniappan, A. C. King, and S. P. Fortmann
Depression and the Metabolic Syndrome in Young Adults: Findings From the Third National Health and Nutrition Examination Survey
Psychosom Med, May 1, 2004; 66(3): 316 - 322.
[Abstract] [Full Text] [PDF]


Home page
Recent Prog Horm ResHome page
J. R. Seckl, N. M. Morton, K. E. Chapman, and B. R. Walker
Glucocorticoids and 11beta-Hydroxysteroid Dehydrogenase in Adipose Tissue
Recent Prog. Horm. Res., January 1, 2004; 59(1): 359 - 393.
[Abstract] [Full Text]


Home page
CirculationHome page
D. J. Brotman, J. P. Girod, L. B. Tanko, Y. Z. Bagger, P. Alexandersen, C. Christiansen, and P. J. Larsen
Can Glucocorticoid Homeostasis Explain the Antiatherogenic Effect of Peripheral Adiposity? * Reply
Circulation, August 26, 2003; 108 (8): e61 - e61.
[Full Text] [PDF]


Home page
Int J EpidemiolHome page
K. Rennie, N McCarthy, S Yazdgerdi, M Marmot, and E Brunner
Association of the metabolic syndrome with both vigorous and moderate physical activity
Int. J. Epidemiol., August 1, 2003; 32(4): 600 - 606.
[Abstract] [Full Text] [PDF]


Home page
QJMHome page
A.M.V. Ward, A. Jones, and D.I.W. Phillips
Stress, disease and 'joined-up' science
QJM, July 1, 2003; 96(7): 463 - 464.
[Full Text] [PDF]


Home page
CirculationHome page
P. Hjemdahl
Stress and the Metabolic Syndrome: An Interesting but Enigmatic Association
Circulation, November 19, 2002; 106(21): 2634 - 2636.
[Full Text] [PDF]